Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

BACKGROUND: Systemic lupus erythematosus (SLE) patients have a striking increase in cardiovascular (CV) comorbidity not fully explained by the Framingham risk score. Recent evidence from in vitro studies suggests that type I interferons (IFN) could promote premature CV disease (CVD) in SLE. We asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Somers, Emily C., Zhao, Wenpu, Lewis, Emily E., Wang, Lu, Wing, Jeffrey J., Sundaram, Baskaran, Kazerooni, Ella A., McCune, W. Joseph, Kaplan, Mariana J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351452/
https://www.ncbi.nlm.nih.gov/pubmed/22606325
http://dx.doi.org/10.1371/journal.pone.0037000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351452/
https://www.ncbi.nlm.nih.gov/pubmed/22606325
http://dx.doi.org/10.1371/journal.pone.0037000

Ejemplares similares